equol has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, F; Li, J; Wu, XN; Yang, ZP; Yao, YH; Zhao, Y | 1 |
| Bennett, FI; Jackson, MD; McFarlane-Anderson, ND; Simon, GA; Walker, SP | 1 |
2 other study(ies) available for equol and Carcinoma
| Article | Year |
|---|---|
Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Activation; Equol; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Oncogene Proteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Stomach Neoplasms; Time Factors | 2015 |
Urinary phytoestrogens and risk of prostate cancer in Jamaican men.
Topics: Aged; Carcinoma; Case-Control Studies; Equol; Genistein; Humans; Isoflavones; Jamaica; Lignans; Male; Middle Aged; Phytoestrogens; Prostatic Neoplasms; Risk | 2010 |